ActiveNANCT06523569

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

Sponsor: Northwestern University

Trial Details

Condition	Hypertension in Pregnancy, Pre-Eclampsia, Eclampsia, Gestational Hypertension
Intervention	Digital Blood Pressure Monitoring System; Mobile health application
Phase	NA
Status	Active
Participants	120
Est. Completion	1 Dec 2026
Last Updated	8 June 2026

Primary Outcome

Systolic blood pressure

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Delivery at Northwestern Memorial Hospital (Prentice Women's Hospital) * Live birth at any gestational age * Pregnancy complicated by new-onset HDP (pre-eclampsia, eclampsia, or gestational hypertension) Exclusion Criteria: * HELLP syndrome * History of chronic diseases pre-pregnancy (hypertension, diabetes, cardiovascular disease, chronic renal disease) * Current Omron remote patient monitoring or Noom user * BMI\<18.5 kg/m2 at enrollment * Inadequate gestational weight gain or gestational weight loss

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Digital Health Trial Targets Post-Pregnancy Cardiovascular Risk: Mobile BP Monitoring After Hypertensive Disorders

Northwestern University trial tests digital blood pressure monitoring and mobile health apps to reduce cardiovascular disease risk in women who experienced hypertensive disorders during pregnancy. The 120-participant study addresses the critical care gap in postpartum cardiovascular risk management.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service